Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Best hair growth results from combining finasteride and minoxidil.

Some breast cancer chemotherapy can cause permanent hair loss.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

The research found how GPCR Class A Rhodopsin receptors are related and suggested possible substances they interact with.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Antiandrogen therapy helped increase hair growth in women with hormonal imbalances related to baldness.

Natural molecules like inositols, resveratrol, vitamins, and omega-3 fatty acids may help manage Polycystic Ovary Syndrome (PCOS), but their effects vary and need more exploration.

Low-dose flutamide helps reduce excessive hair growth and is even more effective with birth control, without bad effects on blood fats.

Metformin should be used for PCOS mainly in those with glucose intolerance, and has limited benefits for infertility or hirsutism.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

The document concludes that diagnosing and treating Congenital Adrenal Hyperplasia is complex and requires a team approach due to its effects on the skin and other symptoms.

The spiny mouse is a unique menstruating rodent that can help us understand menstruation and reproductive disorders.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Spironolactone did not make hair thinner in women with excess hair growth.

Sexual orientation does not affect the prevalence of PCOS or fertility rates in women undergoing artificial donor insemination.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

The document concludes that Rabson-Mendenhall syndrome requires novel treatments for insulin resistance and emphasizes the importance of dental care in affected patients.

Finasteride exposure harms tadpole reproduction and hormone balance.